You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 20 No. 2, February 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (70)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CSF Immunoglobulins in Multiple Sclerosis and Other Neurologic Diseases

Measurement by Electroimmunodiffusion

Stuart A. Schneck, MD; Henry N. Claman, MD

Arch Neurol. 1969;20(2):132-139.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MORE than 25 years have passed since Kabat and co-workers,1 using the Tiselius electrophoresis method, first noted that the cerebrospinal fluid (CSF) {gamma}-globulin content was elevated in some patients with multiple sclerosis and neurosyphilis. Many methods have been described subsequently in the search for a rapid, simple, and reliable test which would quantitate the CSF immunoglobulins. The standard for accuracy for all these procedures has been the immunochemical method of Kabat et al.2 Few clinical laboratories use this test, however, for it is time consuming, expensive, and complex. In 1966, a method of electroimmuno-diffusion (EID) suitable for use with minute volumes of unconcentrated CSF was described by Hartley et al.3 It is the purpose of this paper to relate our clinical experience with this test, to compare it with other methods for quantitation of CSF immunoglobulins, and to summarize the available information regarding the value of CSF . . . [Full Text PDF of this Article]


Author Affiliations

Denver

From the Division of Neurology (Dr. Schneck) and the Division of Clinical Immunology (Dr. Claman), University of Colorado Medical Center, Denver.


Footnotes

Submitted for publication June 29, 1968; accepted Sept 23.

Reprint requests to 4200 E Ninth Ave, Denver 80220 (Dr. Schneck).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.